Panaxynol, a Bioactive Component of American Ginseng, Targets Macrophages and Suppresses Colitis in Mice
Overview
Authors
Affiliations
Ulcerative colitis has a significant impact on the quality of life for the patients, and can substantially increase the risk of colon cancer in patients suffering long-term. Conventional treatments provide only modest relief paired with a high risk of side effects, while complementary and alternative medicines can offer safe and effective options. Over the past decade, we have shown that both American ginseng and its hexane fraction (HAG) have anti-oxidant and anti-inflammatory properties that can suppress mouse colitis and prevent colitis-associated colon cancer. With the goal of isolating a single active compound, we further fractionated HAG, and found the most abundant molecule in this fraction was the polyacetylene, panaxynol (PA). After isolating and characterizing PA, we tested the efficacy of PA in the treatment and prevention of colitis in mice and studied the mechanism of action. We demonstrate here that PA effectively treats colitis in a Dextran Sulfate Sodium mouse model by targeting macrophages for DNA damage and apoptosis. This study provides additional mechanistic evidence that American ginseng can be used for conventional treatment of colitis and other diseases associated with macrophage dysfunction.
Antioxidant Therapy in Inflammatory Bowel Diseases: How Far Have We Come and How Close Are We?.
Xavier L, Reis T, da Paz Martins A, Santos J, Bueno N, Goulart M Antioxidants (Basel). 2024; 13(11).
PMID: 39594511 PMC: 11590966. DOI: 10.3390/antiox13111369.
Bullard B, McDonald S, Cardaci T, VanderVeen B, Mohammed A, Kubinak J Am J Physiol Gastrointest Liver Physiol. 2024; 326(5):G591-G606.
PMID: 38469632 PMC: 11376977. DOI: 10.1152/ajpgi.00004.2024.
Harwansh R, Chauhan S, Deshmukh R, Mazumder R Curr Pharm Biotechnol. 2024; 25(14):1835-1857.
PMID: 38310453 DOI: 10.2174/0113892010282432231222060355.
Zhang Q, Chumanevich A, Nguyen I, Chumanevich A, Sartawi N, Hogan J Toxicol Rep. 2023; 11:221-232.
PMID: 37719200 PMC: 10502305. DOI: 10.1016/j.toxrep.2023.08.006.
Benameur T, Porro C, Twfieg M, Benameur N, Panaro M, Filannino F Brain Sci. 2023; 13(8).
PMID: 37626582 PMC: 10452544. DOI: 10.3390/brainsci13081226.